Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study

BACKGROUND: To characterize the clinicopathological features and evaluate the neoadjuvant chemotherapy (NACT) efficacy of patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer. METHODS: A total of 905 breast cancer patients who received 4 cycles of thrice-weekly standard NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lingfeng, Li, Zhenghang, Jiang, Linshan, Shu, Xiujie, Xu, Yingkun, Liu, Shengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810386/
https://www.ncbi.nlm.nih.gov/pubmed/36605428
http://dx.doi.org/10.3389/fonc.2022.999716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810386/
https://www.ncbi.nlm.nih.gov/pubmed/36605428
http://dx.doi.org/10.3389/fonc.2022.999716

Ejemplares similares